Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic
Open Access
- 1 December 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 5 (12), 1419-1424
- https://doi.org/10.1001/jamacardio.2020.3629
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has profoundly changed health care delivery worldwide. Although early attention to COVID-19 was disproportionately focused on efforts to flatten the (pandemic) curve, recent studies have revealed a substantial decrease in hospitalization rates for acute myocardial infarction (AMI). Reports from Austria,1 Italy,2 and the US (California)3 have noted lower admission rates for both ST-segment elevation myocardial infarction (STEMI) and non–ST-segment elevation myocardial infarction (NSTEMI). This decreased hospitalization rate likely reflects multiple factors. Most worrisome among these factors has been the reluctance of patients with AMI to seek medical attention out of fear that they may become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).4Keywords
This publication has 6 references indexed in Scilit:
- The Covid-19 Pandemic and the Incidence of Acute Myocardial InfarctionThe New England Journal of Medicine, 2020
- Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 eraEuropean Heart Journal, 2020
- Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damageEuropean Heart Journal, 2020
- Collateral DamageJACC: Case Reports, 2020
- Management of Acute Myocardial Infarction During the COVID-19 PandemicJournal of the American College of Cardiology, 2020
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, ChinaCirculation: Cardiovascular Quality and Outcomes, 2020